NEW CASTLE, Del., Oct. 5, 2012 (GLOBE NEWSWIRE) -- ScripsAmerica, Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's acquisition target, Marlex Pharmaceuticals, Inc., has shipped and invoiced the first order of an 8 year pharmaceutical distribution contract with the United States Department of Defense and Defense Logistics Agency (DLA).
Last week, the Company initially announced the 8-year government contract, highlighting the distribution component whereby the Office of Health Affairs (OHA), a branch of the U.S. Department of Homeland Security, has agreed to purchase a minimum of $25 million in pharmaceuticals within the first three years.
"The shipment and invoicing of Marlex's first pharmaceutical order to the Department of Defense marks the official start of a multi-year contract, representing a significant milestone for the company. We are very excited by this development and look forward to Marlex and subsequently ScripsAmerica successfully receiving and shipping additional orders for years to come," commented Bob Schneiderman, CEO of ScripsAmerica.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. delivers pharmaceutical products to a wide range of end users across the health care industry, including physicians' offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies through the largest pharmaceutical distributor in North America, McKesson Corporation. Current therapeutic categories serviced by the Company include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. Other customers of ScripsAmerica include Cardinal Health, Curtis Pharmaceuticals, MedVet and the United States Veterans Administration.
For more information please visit: www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT: 888-959-7095Source:ScripsAmerica, Inc.